Alcon Inc. (SWX:ALC)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 23.78B -36.5% |
| Revenue (ttm) | 8.53B +7.1% |
| Net Income | 656.94M -26.9% |
| EPS | 1.34 -25.9% |
| Shares Out | 487.70M |
| PE Ratio | 36.45 |
| Forward PE | 17.27 |
| Dividend | 0.28 (0.57%) |
| Ex-Dividend Date | May 5, 2026 |
| Volume | 2,777,656 |
| Average Volume | 1,603,839 |
| Open | 48.48 |
| Previous Close | 48.75 |
| Day's Range | 48.05 - 50.16 |
| 52-Week Range | 47.80 - 80.96 |
| Beta | 0.70 |
| RSI | 17.84 |
| Earnings Date | May 6, 2026 |
About Alcon
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS... [Read more]
Financial Performance
In 2025, Alcon's revenue was $10.40 billion, an increase of 4.94% compared to the previous year's $9.91 billion. Earnings were $980.00 million, a decrease of -3.73%.
Financial numbers in USD Financial StatementsNews
Alcon price target lowered to $78 from $90 at Barclays
Barclays lowered the firm’s price target on Alcon (ALC) to $78 from $90 and keeps an Equal Weight rating on the shares.
Alcon price target lowered to $90 from $98 at Baird
Baird lowered the firm’s price target on Alcon (ALC) to $90 from $98 and keeps an Outperform rating on the shares. The firm updated its model following results where it
Alcon price target lowered to $85 from $95 at Mizuho
Mizuho lowered the firm’s price target on Alcon (ALC) to $85 from $95 and keeps an Outperform rating on the shares. Published first on TheFly – the ultimate source for
Q1 2026 Alcon AG Earnings Call Transcript
Q1 2026 Alcon AG Earnings Call Transcript
Alcon price target lowered to $70 from $82 at Stifel
Stifel lowered the firm’s price target on Alcon (ALC) to $70 from $82 and keeps a Hold rating on the shares. The firm’s previous downgrade of shares in January questioned
Alcon (ALC) Q1 2026 Earnings Call Transcript
Alcon (ALC) Q1 2026 Earnings Call Transcript
Alcon Earnings Call Transcript: Q1 2026
First quarter sales rose 6% to $2.7B, driven by innovation in surgical equipment, IOLs, and ocular health. Guidance for 2026 remains 5–7% sales growth and 10–13% EPS growth, with new products and AI initiatives supporting future performance.
Swiss eye care firm Alcon's quarterly revenue rises, driven by product launches
Swiss-American eye care company Alcon reported a 10% rise in its quarterly revenue, citing recent product launches as main drivers.
Alcon Q1 Profit Falls
(RTTNews) - Eye care products maker Alcon Inc. (ALC) on Tuesday reported first-quarter results, with profit declining from last year despite an increase in revenues.
New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds
GENEVA--(BUSINESS WIRE)--New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds.
New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds
Regulatory News: Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ending March 31, 2026. For the first quarter of 2026, sales were $2.7 billion,...
Alcon Announces Results of 2026 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Alcon Announces Results of 2026 Annual General Meeting.
Is Alcon Inc (ALC) a Bargain After 3.4% Drop? GF Value Says Undervalued
Is Alcon Inc (ALC) a Bargain After 3.4% Drop? GF Value Says Undervalued
Alcon Inc (ALC) Stock Down 3.1% -- Now Undervalued? GF Score: 80/100
Alcon Inc (ALC) Stock Down 3.1% -- Now Undervalued? GF Score: 80/100
Alcon price target lowered to $87 from $92 at BTIG
BTIG analyst Ryan Zimmerman lowered the firm’s price target on Alcon (ALC) to $87 from $92 and keeps a Buy rating on the shares as part of a broader research
Mexican Gold Mining Corp.: Mexican Gold Mining Corp. and Alcon Silver Corp. Announce Arrangement Agreement to Create a Diversified Precious Metals Exploration Company
Vancouver, British Columbia--(Newsfile Corp. - April 9, 2026) - Mexican Gold Mining Corp. (TSXV: MEX) ("Mexican Gold" or the "Purchaser") and Alcon Silver Corp. ("Alcon" or the "Company") are plea...
Alcon Inc (ALC) Trading 3.96% Higher on Apr 8
Alcon Inc (ALC) Trading 3.96% Higher on Apr 8
Alcon (ALC) Launches Clareon TruPlus Intraocular Lens in the U.S.
Alcon (ALC) Launches Clareon TruPlus Intraocular Lens in the U.S.
Alcon launches Clareon TruPlus at ASCRS 2026
Alcon (ALC) announced the U.S. launch of Clareon TruPlus, its new enhanced design monofocal and toric intraocular lens, at the American Society of Cataract and Refractive Surgery Annual Meeting in
Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026
FORT WORTH, Texas--(BUSINESS WIRE)--Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026.
Alcon Publishes Agenda for 2026 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2026 Annual General Meeting.
Alcon (ALC) Faces $34 Million Verdict in Patent Case
Alcon (ALC) Faces $34 Million Verdict in Patent Case
Sight Sciences awarded monetary damages by district court against Alcon
Sight Sciences (SGHT) announced that the U.S. District Court for the District of Delaware issued an order on post-trial motions in Sight Sciences’ patent infringement case against Alcon (ALC) original...
Lensar upgraded to Buy from Neutral at BTIG
BTIG upgraded Lensar (LNSR) to Buy from Neutral with a $10 price target. Prior to the Alcon (ALC) acquisition announcement in March of last year, Lensar was seeing strong growing
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review
LENSAR Inc. (NASDAQ: LNSR) shares are down during Tuesday’s premarket session following the termination of a merger agreement with Alcon AG (NYSE: ALC). In March 2025, Alcon agreed to acquire the la...